Cargando…
Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19
Antibacterial prescribing in patients presenting with COVID-19 remains discordant to rates of bacterial co-infection. Implementing diagnostic tests to exclude bacterial infection may aid reduction in antibacterial prescribing. (1) Method: A retrospective observational analysis was undertaken of all...
Autores principales: | Hughes, Stephen, Mughal, Nabeela, Moore, Luke S. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468005/ https://www.ncbi.nlm.nih.gov/pubmed/34572701 http://dx.doi.org/10.3390/antibiotics10091119 |
Ejemplares similares
-
C-reactive protein-guided use of procalcitonin in COVID-19
por: Houghton, Rebecca, et al.
Publicado: (2021) -
Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2019) -
COVID-19 and fungal superinfection
por: Heard, Katie L, et al.
Publicado: (2020) -
Antibiotic prescribing patterns for coronavirus disease 2019 (COVID-19) in two emergency departments with rapid procalcitonin
por: Pulia, Michael S., et al.
Publicado: (2020) -
Optimization of antimicrobial dosing in patients with acute kidney injury: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2022)